Related references
Note: Only part of the references are listed.Vitamin e supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype - A prospective double-blinded clinical trial
Uzi Milman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes
Tina Costacou et al.
DIABETES (2008)
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
Rabea Asleh et al.
DIABETES (2008)
Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease
Shany Blum et al.
PHARMACOGENOMICS (2008)
HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes
Per-Henrik Groop et al.
DIABETES CARE (2007)
The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction
Zhiping Wu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
Differential association of hemoglobin with proinflammatory high density lipoproteins in Atherogenic/Hyperlipidemic mice - A novel biomarker of atherosclerosis
Junji Watanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase
E. Nobecourt et al.
DIABETOLOGIA (2007)
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
G. M. Anantharamaiah et al.
JOURNAL OF LIPID RESEARCH (2007)
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL
Tomas Vaisar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo
Rabea Asleh et al.
CIRCULATION RESEARCH (2006)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
Modified HDL: Biological and physiopathological consequences
Giuseppe Danilo Norata et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I
BH Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural modifications of HDL and functional consequences
G Ferretti et al.
ATHEROSCLEROSIS (2006)
Proteomic analysis of high-density lipoprotein
F Rezaee et al.
PROTEOMICS (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Mechanisms of disease: proatherogenic HDL - an evolving field
Mohamad Navab et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction
M Suleiman et al.
DIABETES (2005)
Vitamin E in the primary prevention of cardiovascular disease and cancer - The Women's Health Study: A randomized controlled trial
IM Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity
ET Alexander et al.
BIOCHEMISTRY (2005)
Assignment of the binding site for haptoglobin on apolipoprotein A-I
MS Spagnuolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL
VV Bamm et al.
BIOCHEMISTRY (2004)
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes
AP Levy et al.
DIABETES CARE (2004)
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes
A Roguin et al.
DIABETES CARE (2003)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The strong heart study
AP Levy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women - A randomized controlled trial
DD Waters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Structure-function analysis of the antioxidant properties of haptoglobin
M Melamed-Frank et al.
BLOOD (2001)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
